{"cmr":"fr-cm-kg/XPAR/FR0012127173","since":null,"total":33,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-11-02","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1147846","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1147846","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DIFA9T7hHCl-mxTyRpvKdVZauCnloAzQ4pq9CK1zSK7kAF78x2jMOuKwpjOdNtfNn8C1LvAqaEEkkIRnVMlsDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-29","event_type":"newswire_release","title":"OSE Immunotherapeutics annonce des résultats positifs","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/29/3391736/0/fr/ose-immunotherapeutics-annonce-des-r%C3%A9sultats-positifs-compl%C3%A9mentaires-de-l-%C3%A9tude-de-phase-2-randomis%C3%A9e-combi-ted-de-tedopi-ose2101-dans-le-cancer-du-poumon-non-%C3%A0-petites-cellules-m.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"YGRvncNe7HQpIePdPulZXWGa_Ab8kA5ivSMyh6KCCfVwIaEhRVDh9AgmwvgL92CVHJ7AUoTP-m-WbOwFoxfqBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-29","event_type":"newswire_release","title":"OSE Immunotherapeutics Reports Additional Positive Results","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/29/3391736/0/en/ose-immunotherapeutics-reports-additional-positive-results-of-combi-ted-phase-2-randomized-trial-with-tedopi-ose2101-in-metastatic-non-small-cell-lung-cancer.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qFTHvzHE2IdZwa_FBMKusclhVzKLk0pY35_UYTiU4uON596NY-OSs3QPC3-TTtUel25PnBexMWpOXzfZVRLtDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-28","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1146866","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1146866","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aix9wXouLa14pY8kQAN4W9kPyQNP8jr47vCjXUdDX4NqMKTUQKdU8Oans4HAtB5vPFfWuGRAT2rK79Ov7BDcBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-23","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1146075","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1146075","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-eRoKL7szpw76pmCuQApxJxDAPUnqCd-dUUT9sXOnMsXwsCXzrEhJcd9yQEm_KBd_hY9szncrrgfrsxGcJo7CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-22","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1145710","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1145710","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AaI1pcqcxhqUO3dbDB8uPVtonER3lryrXND_Xuu429sVz7_wy8-lS82ebP3ewtzVKsvtxiIZWrn1gjRRnnzGAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-21","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1145456","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1145456","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iowiYgOtUVkG3M1sXHMrHIURnbMVuYaIYBb2VIkRtopXuvaI6M1Vo_yK2DJUTGsv1EZGknGcqZstEYRpzuOvDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-10-14","event_type":"regulatory_filing","title":"DeclarationPositionsCourtes [VAD]","reference":"2026E1144237","category":"VAD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026E1144237","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationPositionsCourtes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1VYS0BNQ3Q0aUAWJO2hVmZ-EDkg13B46wWlVMsa43TwwQQ5Pwbc-5BZuQGyduRGNDsOy5hWuIbSclcbvg97gAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-09-28","event_type":"newswire_release","title":"OSE Immunotherapeutics Reports its Cash Position as of June","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/28/3369498/0/en/ose-immunotherapeutics-reports-its-cash-position-as-of-june-30-2026-and-provides-business-update.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NQyrtegR-qFa66CbKHyd2qbf2wspX3vJP8h6i8-pAhsZzpXC_Yw8AJyF3Aay5i2LzH5WF4e-18lXDPI9f0JpDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-09-28","event_type":"newswire_release","title":"OSE Immunotherapeutics publie sa position de trésorerie au","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/28/3369498/0/fr/ose-immunotherapeutics-publie-sa-position-de-tr%C3%A9sorerie-au-30-juin-2026-et-fait-un-point-sur-ses-activit%C3%A9s.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qm5nsftICsiQOp28Hh8431JqxVsohxP30ggeos5X2IeqjOkZBXZ251-2yZgR057VRRzZ7XFJkAdH1fNRjQHgAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-09-09","event_type":"newswire_release","title":"OSE Immunotherapeutics Welcomes First Patient Dosed by","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/09/3358940/0/en/ose-immunotherapeutics-welcomes-first-patient-dosed-by-veloxis-in-the-phase-2-rengevity-201-trial-evaluating-pegrizeprument-vel-101-for-the-prevention-of-organ-rejection-in-kidney-.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CdkEdxkgywj68pNrqFHpjorHNnmZ6u296jOLfGfd3Dy25pm7twmwf0hsggxQec-MaSXogZgieikkcYY_6q-jDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-06-05","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1118892","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1118892","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g85C4L0xFKUs2j-MoEOyAj9R4nQpNUgNwuBjZuHVb0pprzpvUMmU7gvbPpGvg63fYjtHiSImfXrs3YGkPn6NCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-06-05","event_type":"prospectus","title":"DocumentEnregistrementUniversel [VISA]","reference":"D.26-0405","category":"VISA","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/D.26-0405","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DocumentEnregistrementUniversel; documents 2; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5OHZzjIvIM0wpsZUFHy_tB-t8tqUqwy_ZVV16lPhHN7kRePTENcIC0C8gDxd0AEhdEaUv-LyCS7ZK2bDXh4ZBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-04-23","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces Presentation of TEDOVA","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/23/3279568/0/en/ose-immunotherapeutics-announces-presentation-of-tedova-phase-2-topline-results-of-tedopi-in-ovarian-cancer-at-the-asco-2026-meeting.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DZEwSvDczQufFwUu_ilAD0w6IuqhUIQky0jht-pUiaxuJMX4bLGRjSAw_6FkDPQMEtv5RdRJN8IRVfH_nSCpCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2026-03-16","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces its 2026 Financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/16/3255985/0/en/OSE-Immunotherapeutics-Announces-its-2026-Financial-Calendar.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AdWownd_ONWHm0jgG83QgcTg9oelq6qN_7HrkmGGAWfwWNSFOepBN9Z0a8Iy5o1Udg4KjEFfZFxIM-SPuaHtCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-12-13","event_type":"newswire_release","title":"MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/13/3204966/0/en/MLTX-FRAUD-UPDATE-Important-MoonLake-Immunotherapeutics-Securities-Fraud-Class-Action-Deadline-is-Approaching-for-Investors-Contact-BFA-Law-before-December-15.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aXtKK6HWEPxS4adla_UdSzYFjYVH3aaD43CD5GYG8-trhxSmaNo_mPW0iuMQcPWKFHF1enErKvWY2zHcBb6tBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-12-08","event_type":"newswire_release","title":"MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-302634964.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rA4wBZ0uGVjq7Gwn9NTge_VVWMbv-weWknflFSllNNTFmT0gl_4DMAsYYwguUgY-gPyhmwf6uI6o5afRHABHDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-12-08","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces Strategic Amendment to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/08/3201201/0/en/OSE-Immunotherapeutics-Announces-Strategic-Amendment-to-AbbVie-s-Partnership-on-ABBV-230-Development.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"u6N7WDdcYZGJ_07uk-YrpYbouayngMJxyRqyAxyZRgzskE2fIc1FVO21Qecz1DxfBHdXTOYd0F7VcguBDzOUCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-12-08","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces Strategic Amendment to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/de/news-release/2025/12/08/3201201/0/en/OSE-Immunotherapeutics-Announces-Strategic-Amendment-to-AbbVie-s-Partnership-on-ABBV-230-Development.html?f=22&fvtc=5&fvtv=35727333","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hYtonLlULXkZVnjxtwj7EFqwepNJ5uCU9OrY7gUw4pSWDJEIW_21XwJjKlFBYUT-xsBLMcwkvYI1gMp3OkLaDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-12-08","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces Strategic Amendment to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2025/12/08/3201201/0/en/OSE-Immunotherapeutics-Announces-Strategic-Amendment-to-AbbVie-s-Partnership-on-ABBV-230-Development.html?f=22&fvtc=5&fvtv=32375057","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nfV9BbMWvI5oXmzqml7QFBA9q7mAJ_oTyPezVG3uczK1rXdC83jlnRgEi1E2eSKZLPuUkifgHj5Ec0ogO-IVCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-27","event_type":"newswire_release","title":"MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/27/3195624/0/en/MLTX-INVESTMENT-MoonLake-Immunotherapeutics-Investors-with-Losses-may-have-Rights-in-Securities-Class-Action-Contact-BFA-Law-by-December-15-Deadline.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_cmBXR6LCWcxJ1bo1OAq-o4c4Pgkup6b1dwZ-o05VHCezdEGg1FCq-rUxvHlyEtTnNr71XRl2Y2rDztd_pU0Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-23","event_type":"newswire_release","title":"MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15 - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/23/3193145/0/en/MLTX-COURT-ALERT-MoonLake-Immunotherapeutics-Investors-that-Lost-Money-May-have-been-Affected-by-Fraud-Contact-BFA-Law-by-December-15.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rCa4ybzPucwgaQROG57OMKsh5nH7cPZJo-FSe3o3ig0ZcMEJFT1wSdp7pp7iy_mMkULR-AMZ6JNx_nXkuAAuDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-17","event_type":"newswire_release","title":"OSE Immunotherapeutics Announces Positive Recommendation","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/17/3189428/0/en/OSE-Immunotherapeutics-Announces-Positive-Recommendation-from-Independent-Data-Monitoring-Committee-IDMC-to-Continue-Pivotal-Phase-3-ARTEMIA-Trial-Evaluating-Tedopi-in-Non-Small-Ce.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"WW1bPSP8KF7Z9RYshRI3MBj6UoNwYZyIFN8VLDOrk4lZoBXP42Au6Ua3mmUpt6pMtjfWOwWqrgF7ZCZ7f9dhCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-15","event_type":"newswire_release","title":"STOCK ALERT: MoonLake Immunotherapeutics (MLTX) Investors - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/15/3188699/0/en/STOCK-ALERT-MoonLake-Immunotherapeutics-MLTX-Investors-may-be-Eligible-for-Compensation-in-Securities-Class-Action-Contact-BFA-Law-by-December-15-Deadline.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g3mIvxHJW9Kk1UXFarSMADmS43wPLPChyHt0aFrwmWnxXHDsDRWLbhaP8TiYMvSmWyBY-5fh_Gy4aXvSzVw9Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-09","event_type":"newswire_release","title":"MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/09/3184117/0/en/MLTX-CLASS-REMINDER-MoonLake-Immunotherapeutics-Investors-with-Losses-May-have-been-Affected-by-Fraud-Contact-BFA-Law-by-December-15-Legal-Deadline.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"icKiveCnBPcPPFdTU_piaPQI4snz860HRkL1mnihx4kXt10vvB7LfwyElxtCLxBx4C2yjnZXyhwKWnePkPdPCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-11-01","event_type":"newswire_release","title":"MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/01/3178716/0/en/MLTX-INVESTOR-REMINDER-MoonLake-Immunotherapeutics-Investors-may-have-been-Affected-by-Fraud-Contact-BFA-Law-if-You-Suffered-Losses.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5YLOV0sNg-VfbHTvJuJ3sH47LJEKRjI7nZiYy9qBjXxVJh3NG9CVIJPmUuSAp5GgRRkSOhErdvh0PI30gu2JAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-10-07","event_type":"regulatory_filing","title":"Declarations, Pactes [SPDE]","reference":"225C1701","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1701","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations, Pactes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"stLD-qvgdgsOSMlQma1Vb185bwlqZl0BH2lzCgl5Ka4cF_hUVR9D_kKk4gFxcqDoSoWTwWYofLgYSEvgIzc2CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-10-04","event_type":"newswire_release","title":"MLTX LEGAL NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Investigation due to Drug Trial Results – Contact BFA Law if You Lost Money - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/10/04/3161271/0/en/MLTX-LEGAL-NOTICE-MoonLake-Immunotherapeutics-Faces-Securities-Fraud-Investigation-due-to-Drug-Trial-Results-Contact-BFA-Law-if-You-Lost-Money.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'immunotherapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GOxyD6hvQsOnUibRg7lxsQqn4SjI0Vknj2CP27RwBx6xrDNWko6-D3-_7oEgWeXpln0Y3t_QFUystsxMp6TBBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-09-30","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1663","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1663","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"OaYeB5Y2ScIZ40buXgMaPZZMwvyZ29t8-hp_1Dv9sYehDw5AwBRTpev8GHsZNs60xmDMWfgrcxlqzeshwtDpBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-09-22","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2025DD1059118","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2025DD1059118","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2IMt3V4j3PDtxUo0ADU2uOSBdn8WoIIirazDS7NuuvBeKqK0V1hZLXHoMrLmXHV6hq_W-R44LAX15GGbvVaGBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-09-22","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2025DD1058931","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2025DD1058931","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9bGQ_AwWESJzP2X5t2ZviFVQgfjLRQPE4jbNgjPB3H-3KB3ocHFDfxHY8QngzdHU2SUbW82SwvwdPn_jNwBoAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-09-18","event_type":"regulatory_filing","title":"Declarations, Pactes [SPDE]","reference":"225C1578","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1578","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations, Pactes; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rveQmdqH--MLq0K7n5yHFgIdgVMoa20kzg5S0GIrzXRK25-hx4ZEKakpz3JowPloldG4vH2O-_6gqeeJWgccCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012127173","date":"2025-09-11","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1514","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1514","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer OSE IMMUNOTHERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-H_vjvMami-lb23T_4cCQYXddnioGXWFPCGLuudTXxPtoH8XHGt906EMnFYtwoEYh8OIG0p2S74YXRQFrsVoBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}